536 related articles for article (PubMed ID: 25615529)
1. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
Huang L; Liu X; Cheng B; Huang K
Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529
[TBL] [Abstract][Full Text] [Related]
2. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
Chiti F; Dobson CM
Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
[TBL] [Abstract][Full Text] [Related]
3. Role of water in protein folding, oligomerization, amyloidosis and miniprotein.
Vajda T; Perczel A
J Pept Sci; 2014 Oct; 20(10):747-59. PubMed ID: 25098401
[TBL] [Abstract][Full Text] [Related]
4. Implications of protein structure instability: from physiological to pathological secondary structure.
Sukhanova A; Poly S; Shemetov A; Bronstein I; Nabiev I
Biopolymers; 2012 Aug; 97(8):577-88. PubMed ID: 22605549
[TBL] [Abstract][Full Text] [Related]
5. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
Nerelius C; Fitzen M; Johansson J
Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101
[TBL] [Abstract][Full Text] [Related]
6. Diethylpyrocarbonate modification reveals HisB5 as an important modulator of insulin amyloid formation.
Yang X; Li Y; Huang L; Zhang X; Cheng C; Gong H; Ma L; Huang K
J Biochem; 2015 Jan; 157(1):45-51. PubMed ID: 25172962
[TBL] [Abstract][Full Text] [Related]
7. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies.
Salahuddin P; Khan RH; Furkan M; Uversky VN; Islam Z; Fatima MT
Int J Biol Macromol; 2021 Sep; 186():580-590. PubMed ID: 34271045
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations of amyloid fibrils: an in silico approach.
Ye W; Wang W; Jiang C; Yu Q; Chen H
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):503-8. PubMed ID: 23532062
[TBL] [Abstract][Full Text] [Related]
10. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.
Foguel D; Silva JL
Biochemistry; 2004 Sep; 43(36):11361-70. PubMed ID: 15350123
[TBL] [Abstract][Full Text] [Related]
11. Chaperone-like Activity of Calnuc Prevents Amyloid Aggregation.
Kanuru M; Aradhyam GK
Biochemistry; 2017 Jan; 56(1):149-159. PubMed ID: 27997158
[TBL] [Abstract][Full Text] [Related]
12. Starting at the beginning: endoplasmic reticulum proteostasis and systemic amyloid disease.
Romine IC; Wiseman RL
Biochem J; 2020 May; 477(9):1721-1732. PubMed ID: 32412081
[TBL] [Abstract][Full Text] [Related]
13. The amyloid interactome: Exploring protein aggregation.
Biza KV; Nastou KC; Tsiolaki PL; Mastrokalou CV; Hamodrakas SJ; Iconomidou VA
PLoS One; 2017; 12(3):e0173163. PubMed ID: 28249044
[TBL] [Abstract][Full Text] [Related]
14. Insights into amyloid-like aggregation of H2 region of the C-terminal domain of nucleophosmin.
Russo A; Diaferia C; La Manna S; Giannini C; Sibillano T; Accardo A; Morelli G; Novellino E; Marasco D
Biochim Biophys Acta Proteins Proteom; 2017 Feb; 1865(2):176-185. PubMed ID: 27865970
[TBL] [Abstract][Full Text] [Related]
15. Anti-Amyloid Drug Screening Methods Using Bacterial Inclusion Bodies.
Caballero AB; Gamez P; Sabate R; Espargaró A
Methods Mol Biol; 2022; 2538():165-188. PubMed ID: 35951300
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration.
Rozemuller AJ; Jansen C; Carrano A; van Haastert ES; Hondius D; van der Vies SM; Hoozemans JJ
Neurodegener Dis; 2012; 10(1-4):301-4. PubMed ID: 22398730
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Amyloid States by Molecular Chaperones.
Wentink A; Nussbaum-Krammer C; Bukau B
Cold Spring Harb Perspect Biol; 2019 Jul; 11(7):. PubMed ID: 30755450
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
Horvath I; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12473-12477. PubMed ID: 27791129
[TBL] [Abstract][Full Text] [Related]
19. Exploring critical determinants of protein amyloidogenesis: a review.
Sarkar N; Dubey VK
J Pept Sci; 2013 Sep; 19(9):529-36. PubMed ID: 23873708
[TBL] [Abstract][Full Text] [Related]
20. Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.
Gong H; Yang X; Zhao Y; Petersen RB; Liu X; Liu Y; Huang K
Curr Protein Pept Sci; 2015; 16(2):135-46. PubMed ID: 25692950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
